This inventor holds 1 USPTO granted patent. Top assignees: Jcr Pharmaceuticals Co., Ltd., Waseda University. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2014
Title: Innovating Drug Delivery: The Contributions of Shuji Hisamoto
Introduction: Shuji Hisamoto, an ingenious inventor based in Tokyo, Japan, has made notable strides in the field of drug delivery systems. With a focus on creating efficient drug carriers, Hisamoto has secured one patent aimed at enhancing pharmacokinetics, ultimately benefiting medicinal practices.
Latest Patents: Hisamoto's patent, titled "Drug Carrier," addresses a critical challenge in drug delivery: controlling in vivo pharmacokinetics. This innovative drug carrier comprises a molecular assembly that integrates a drug into its structure. The invention takes advantage of the amphiphilic molecules within the assembly; these molecules can be released in response to external environmental changes. By shifting the hydrophilic-hydrophobic balance, the drug carrier facilitates the targeted release of medication, promising improved therapeutic outcomes.
Career Highlights: Throughout his career, Shuji Hisamoto has had the opportunity to work with reputable organizations, including JCR Pharmaceuticals Co., Ltd. and Waseda University. His role in these institutions has contributed to the development of cutting-edge technologies in drug delivery.
Collaborations: Hisamoto's work has often involved collaboration with talented individuals in the field, including notable coworkers such as Shinji Takeoka and Yosuke Okamura. These partnerships have played a significant role in advancing research and innovation in drug carrier technologies.
Conclusion: Shuji Hisamoto exemplifies the spirit of innovation within the drug delivery sector. Through his patented invention, he has laid the groundwork for more effective drug carriers, showcasing the potential for advancements in medical treatments. His contributions reflect the importance of collaboration and research in driving technology forward.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile